XML 62 R51.htm IDEA: XBRL DOCUMENT v3.20.2
BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Assets and Liabilities of Businesses Held for Sale, Narrative (Details) - BioPharma
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
Jun. 30, 2020
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Pretax gain on sale   $ 12,341
Disposed of by sale    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Consideration $ 21,149 21,149
Consideration, cash 20,732 20,732
Consideration, pension liabilities assumed 417 417
Cash payments associated with transaction $ 154 154
Pretax gain on sale   12,341
Gain on sale, after tax   $ 11,199